These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 31767176)

  • 1. Diabetic kidney diseases revisited: A new perspective for a new era.
    Fu H; Liu S; Bastacky SI; Wang X; Tian XJ; Zhou D
    Mol Metab; 2019 Dec; 30():250-263. PubMed ID: 31767176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
    Zheng W; Guo J; Liu ZS
    Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.
    Kato M; Natarajan R
    Nat Rev Nephrol; 2019 Jun; 15(6):327-345. PubMed ID: 30894700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting DNA methylation in diabetic kidney disease: A new perspective.
    Akhouri V; Majumder S; Gaikwad AB
    Life Sci; 2023 Dec; 335():122256. PubMed ID: 37949210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: the role of epigenetics in the metabolic memory of diabetic complications.
    Chen Z; Malek V; Natarajan R
    Am J Physiol Renal Physiol; 2024 Sep; 327(3):F327-F339. PubMed ID: 38961840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modification in diabetic kidney disease.
    Liu Z; Liu J; Wang W; An X; Luo L; Yu D; Sun W
    Front Endocrinol (Lausanne); 2023; 14():1133970. PubMed ID: 37455912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on systems biology applications in diabetic kidney disease.
    Komorowsky CV; Brosius FC; Pennathur S; Kretzler M
    J Cardiovasc Transl Res; 2012 Aug; 5(4):491-508. PubMed ID: 22733404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.
    Guo J; Liu Z; Gong R
    Clin Sci (Lond); 2019 Jun; 133(12):1321-1339. PubMed ID: 31221822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Risk Profile of Diabetic Kidney Disease in High-Risk Populations.
    Xu L; Natarajan R; Chen Z
    Curr Diab Rep; 2019 Feb; 19(3):9. PubMed ID: 30730019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Novel Key Molecular Signatures in the Pathogenesis of Experimental Diabetic Kidney Disease.
    Diao M; Wu Y; Yang J; Liu C; Xu J; Jin H; Wang J; Zhang J; Gao F; Jin C; Tian H; Xu J; Ou Q; Li Y; Xu G; Lu L
    Front Endocrinol (Lausanne); 2022; 13():843721. PubMed ID: 35432190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the role of immunity and inflammation in diabetic kidney disease in the omics era.
    Hu X; Chen S; Ye S; Chen W; Zhou Y
    Front Immunol; 2024; 15():1342837. PubMed ID: 38487541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dynamics and diabetic kidney disease: Missing pieces for the puzzle of therapeutic approaches.
    Narongkiatikhun P; Chattipakorn SC; Chattipakorn N
    J Cell Mol Med; 2022 Jan; 26(2):249-273. PubMed ID: 34889040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research advance in the mechanism for oxidative stress-induced podocyte injury in diabetic kidney disease.
    Ao L; Xie Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1403-1408. PubMed ID: 35232911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What's New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances.
    Watanabe K; Sato E; Mishima E; Miyazaki M; Tanaka T
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease.
    Kourtidou C; Tziomalos K
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Promise of Systems Biology for Diabetic Kidney Disease.
    Brosius FC; Ju W
    Adv Chronic Kidney Dis; 2018 Mar; 25(2):202-213. PubMed ID: 29580584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
    Helou N; Dwyer A; Shaha M; Zanchi A
    JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive Assessment of Diabetic Kidney Disease With MRI: Hype or Hope?
    Zhao K; Seeliger E; Niendorf T; Liu Z
    J Magn Reson Imaging; 2024 May; 59(5):1494-1513. PubMed ID: 37675919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Functional Role of microRNAs and mRNAs in Diabetic Kidney Disease: A Review.
    Rai B; Srivastava J; Saxena P
    Curr Diabetes Rev; 2024; 20(6):e201023222412. PubMed ID: 37867275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage polarization and signaling in diabetic kidney disease: a catalyst for disease progression.
    Youssef N; Noureldein MH; Riachi ME; Haddad A; Eid AA
    Am J Physiol Renal Physiol; 2024 Mar; 326(3):F301-F312. PubMed ID: 38153850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.